Ascendis Pharma A/S Ordinary Share (ASND) Price and Market Data

Ascendis Pharma A/S is a biopharmaceutical company focused on improving patient outcomes through its proprietary TransCon technology platform. The company’s pipeline spans endocrinology and oncology, including candidates such as TransCon PTH, TransCon CNP, and other therapies. Ascendis Pharma operates across the United States, Europe, and other international markets, with most of its revenue generated in the United States.